Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Condition: Chemotherapy-induced Thrombocytopenia Interventions: Drug: Romiplostim; Drug: Placebo Sponsor: Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Research | Study | Thrombocytopenia